Home » News » Awards & Advancement » Hybrigenics names Munoz to its board of directors

Hybrigenics names Munoz to its board of directors

Thursday, October 6, 2011

Hybrigenics has named Dr. Alain Munoz to its board as a non-executive independent director. Munoz replaces Dr. Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.

Munoz, cardiologist and anesthesiologist by training, has over 20 years’ experience in the pharmaceutical industry at senior management level with the Sanofi Group as R&D vice president and the French pharmaceutical company Fournier as VP of R&D and business development.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!